India Ratings and Research (Ind-Ra) has upgraded Marksans Pharma (MPL) long-term issuer rating to 'IND A' from 'IND A-'. The outlook is stable.
http://www.myiris.com/news/sector/ind-ra-upgrades-marksans-pharma-to-ind-a/20150904113138043
Subscribe To Our Free Newsletter |